Invitation letter for COVID-19 vaccination for people aged 85-89 years arriving today Today, the first 50,000 people in the age group from 85-89 years in the Netherlands will receive an invitation from RIVM for a COVID-19 vaccination.
COVID-19 vaccinations for first residents of nursing homes and small-scale residential facilities Today, the first COVID-19 vaccines will be administered to residents of nursing homes and care facilities for people with intellectual disabilities in the Netherlands.
First COVID-19 vaccination in the Netherlands given at GGD vaccination site in Veghel Care workers in nursing homes and small-scale residential facilities received the first COVID-19 vaccinations in the Netherlands this morning at the GGD vaccination location ‘Hart voor Brabant’ in
Care workers in nursing homes and small-scale residential facilities invited for COVID-19 vaccination starting today As of today, the ca. 269,000 care workers of nursing homes and small-scale residential facilities in the Netherlands are invited to make an appointment for a COVID-19 vaccination.
Report on the developments of the National Immunisation Programme: national immunisation coverage increased slightly for the first time in five years National immunisation coverage has increased for the first time in five years, for almost all vaccinations. For children born in 2017, vaccination coverage against mumps, measles and rubella (MMR) increased by 0.7% to 93.6%.
A pregnant woman can protect her baby against whooping cough with 22-week vaccination From 16 December 2019, pregnant women in the Netherlands will be offered the 22-week vaccination. With this vaccination, a pregnant woman protects her child and herself against whooping cough.
Report on the developments of the National Immunisation Programme: stabilisation of participation and low level of disease In the first six months of 2019, the number of notified meningococcal serogroup W (MenW) disease cases decreased in almost all age groups, after a continuous increase since 2015.
Article in The Lancet Infectious Diseases on RIVM research into Maternal pertussis vaccination Scientific journal The Lancet Infectious Diseases has published an article on RIVM research conducted into pertussis vaccination for pregnant women.